brain adenosine levels following hypotension, 3 ischemia, 4 , seizures, 3 and hypoxia 6 and because adenosine is a potent vasodilator. 7 In its proposed role of regulating cerebral blood flow it is speculated that adenosine may be produced at the glial foot process via 5' nucleotidase, 8 released into the extracellular space, and bound to cerebral smooth muscle membranes resulting in relaxation of the vessel. 2 There is some evidence to support this hypothesis. Adenosine receptors Al and A2 have been identified on brain membranes 9 -l0 -l2 and are associated respectively with a decrease and an increase in cyclic AMP production." Furthermore, in- 
Methods

Cell Cultures
Isolation of mouse cerebral microvessels and derivation of cerebral smooth muscle cells and cerebral endothelial cells in tissue culture have previously been described from our laboratory. ]-methionine demonstrates that these cells actively synthesize a-actin, a smooth muscle specific isoactin. No cells in our cultures stained with either anti-factor VIII antibody, an endothelial specific antibody, or anti-GFAP, an astrocyte specific antibody. It is therefore doubtful that our cultures were contaminated with other brain cell types. Stock cultures of the cell lines were maintained in modified Lewis media (MLM) 17 supplemented with 20% fetal bovine serum and were passed twice weekly. All studies were performed on cells prior to passage 10.
Preparation of membranes
Cells were grown to confluence in 100 mm tissue culture dishes, scraped from the plastic with a "rubber policeman", and placed into centrifuge tubes with T ris-HCl buffer solution (pH 7.4, consisting of 50 mM Tris-HCl, 25 mM MgCl 2 and 25 mM CaCl 2 ). Each experiment required cells from 20 dishes. The cells were disrupted in a Polytron (setting 5) for 30 seconds, and centrifuged at 30,000 x g for 10 minutes. The pellet was then frozen at -20°C until use. After thawing, the pellet was resuspended in 50 mM Tris-HCl buffer solution containing adenosine deaminase (Sigma type III, 2 I.U./ml) to destroy endogenous adenosine. This was incubated for 30 minutes at 37°. Following incubation the homogenate was washed twice with 50 mM Tris-HCl and resuspended.
The incubation mixture for binding contained 50 X of homogenate (approximately 0.3-0.8 mg protein) in 50 mM Tris-HCl buffer solution, 10 X of 2-3 H-chloroadenosine (10-12 Ci/mMol, Moravek Biochemicals) and 940 X Tris-HCl buffer to a final volume of 1.0 ml. For determination of nonspecific binding, 10 X of 30.0 mM cold adenosine (Sigma) was added to 50 X of homogenate along with 930 X Tris-HCl buffer and 10 X of 2-3 H-chloroadenosine. The incubation was carried out at 0-4° for 30 minutes. At the end of the incubation 5 ml of ice cold buffer was added to the sample tube, and the sample was poured onto a 25 mm Whatman 6F/B filter under reduced pressure. The filter was then washed two times with 5 ml ice cold buffer. The radioactivity was measured on a Beckmann LS 7800. Protein content was determined by the Lowry protein assay. 18 
Results
The results presented in figure la showed that specific binding of 2- 13 have shown the presence of adenosine receptors coupled to adenylate cyclase activity in brain microvessel fractions using 2-chloroadenosine as a ligand. However, these preparations are impure, including elements such as pericytes, endothelium, smooth muscle, and glia. We have demonstrated a high affinity adenosine receptor for 2- smooth muscle membranes are consistent with this hypothesis. The action of adenosine with the brain microvasculature is undoubtedly complex and its interaction with specific microvascular elements is unclear. It has been shown that adenosine is taken up by isolated micro vessels, 23 cerebral endothelium 24 and cerebral smooth muscle 25 via a carrier-mediated system. Also, the affinity of uptake into isolated cerebral endothelium (Km = 5.0 /xM) is greater than that into isolated cerebral smooth muscle cells (Km = 10.0 jiM). 24 -25 These data suggest that cerebral endothelium may serve to regulate extracellular adenosine concentrations while cerebral smooth muscle serves a more complex role: adenosine may bind to its membrane receptor, possibly resulting in increased intracellular cyclic AMP and vessel relaxation.
Conclusion
We have demonstrated a high affinity adenosine receptor on cerebral smooth cell muscle membranes. These results are consistent with the hypothesis that adenosine regulates cerebral blood flow via action on cerebral smooth muscle.
